Latest Mergers And Acquisitions News

Starpharma has secured a $5.5 million upfront payment from Genentech as part of a new collaboration to develop dendrimer-drug conjugates targeting cancer therapies. The partnership includes potential milestone payments exceeding half a billion dollars and tiered royalties.

MAAS Group Holdings reported a 6% rise in FY25 underlying EBITDA to $219.4 million, driven by strong construction materials growth and strategic acquisitions. The company projects FY26 EBITDA between $240 million and $270 million, underpinned by renewable energy projects and a robust capital recycling program.

Maas Group Holdings delivered a record $219.4 million Underlying EBITDA in FY25, driven by strategic acquisitions and disciplined capital recycling. The company projects further growth with FY26 EBITDA guidance between $240 million and $270 million amid stable market conditions and expanding renewable energy projects.

Aeris Resources reported solid Q1 FY26 results with steady copper and gold production, disciplined cost management, and advancing divestment plans for non-core assets.

Dateline Resources’ Managing Director Stephen Baghdadi has increased his personal investment by exercising 13.86 million options, reinforcing confidence in the Colosseum Gold and Rare Earth Elements Project as feasibility studies progress.

Jupiter Energy reported steady oil sales of US$1.65 million in Q3 2025, all through domestic channels, while nearing completion of a key gas pipeline integration that promises operational efficiencies.

Vitasora Health has received $2.43 million from a cornerstone investor, advancing its $11 million capital raise and reinforcing its path to profitability by Q4 FY2026. The company’s expanding US partnerships and technology investments signal growing market confidence.

Element 25 has appointed Altris Engineering to lead the AU$64.8 million expansion of its Butcherbird manganese mine, a move that underpins its strategy to supply high-purity battery materials to the US electric vehicle market.

Diablo Resources is broadening its North American footprint by preparing for a secondary listing on the U.S. OTCQB market, complementing its recent acquisition of a high-grade silver-antimony project in Utah.

Imricor Medical Systems made significant regulatory strides with FDA submissions for its MRI-guided cardiac ablation devices and launched NorthStar commercially in Europe, even as it reported increased cash outflows in Q3 CY25.

Gorilla Gold Mines Ltd has raised A$31.7 million through a placement to accelerate exploration and resource growth at its key Western Australian gold projects. The capital injection strengthens the company’s cash position to about A$42 million, supporting ongoing and planned drilling campaigns.

Apiam Animal Health Limited has entered a binding agreement with Adamantem Capital Fund II for a $228.4 million acquisition via a scheme of arrangement, offering shareholders a significant premium and flexible cash or scrip consideration options.